Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$192M Buy
3,604,798
+1,447,754
+67% +$78.4M 0.04% 311
2026
Q1
$121M Sell
2,157,044
-2,457,549
-53% -$141M 0.03% 436
2025
Q4
$250M Buy
4,614,593
+2,281,831
+98% +$116M 0.06% 235
2025
Q3
$113M Buy
2,332,762
+406,104
+21% +$20.7M 0.02% 450
2025
Q2
$95.5M Buy
+1,926,658
New +$97.2M 0.02% 486

Other funds holding AMRZ

Barclays's AMRZ Position: Q2 2026 in Review

Barclays increased its Amrize Ltd (AMRZ) stake by 67% in Q2 2026, buying an estimated $78.4M and bringing the position to 3,604,798 shares worth $192M. The position accounts for 0.04% of the portfolio, ranked #311.

Barclays first reported a position in AMRZ in Q2 2025 and has held it in 5 quarters since. The position peaked at $250M in Q4 2025. 463 funds tracked by Wall St. Rank hold AMRZ as of Q2 2026.

  • Barclays held 3,604,798 shares of Amrize Ltd worth $192M as of Q2 2026.
  • Barclays bought 1,447,754 Amrize Ltd shares in Q2 2026, an estimated $78.4M.
  • Amrize Ltd made up 0.04% of Barclays's portfolio in Q2 2026, its #311 holding.
  • Barclays first reported a position in Amrize Ltd in Q2 2025 and has held it in 5 quarters since.
  • Barclays's Amrize Ltd position peaked at $250M in Q4 2025.
  • 463 funds tracked by Wall St. Rank held Amrize Ltd as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.